Tajikistan Transport, Storage, Destruction and Shelf-Life Rules: Extension Ban Explained

1. Key takeaways

Tajikistan applies a standards-procedure-liability three-layer structure to transport, storage and destruction: Article 27(1) assigns the quality and safety requirements for transport and storage to national standards and normative documents; Article 27(2) prohibits extending the expiry period of medicines, and only medicinal substances may have their period of use extended after a comprehensive expert review by the supervisory authority; Article 27(3) requires that medicines and medical products whose expiry period has elapsed must be destroyed, with the destruction procedure determined by the Ministry of Health. GRZAN points out that the prohibition on extending the expiry period is a hard rule, and the provision sets no exception for medical products; device companies that practice deferred release of stock approaching expiry cannot carry that practice over to Tajikistan.

2. Legal basis

3. Expert insights

Insight 1: the prohibition in Article 27(2) targets the expiry period of medicines, and the extension channel is open only to the period of use of medicinal substances. The provision distinguishes two concepts: the expiry period and the period of use. What is prohibited is extension of the former; the latter may be extended after a comprehensive expert review by the supervisory authority. For medical devices, the provision sets no extension channel, so no lawful deferral path exists for devices.

Insight 2: Article 27(3) links the destruction obligation to Article 21(1)(11). An elapsed expiry period is both a withdrawal ground and a direct trigger of the destruction obligation. Combined, the two mean that products whose expiry period has elapsed may not be held in storage pending disposal; they must enter the destruction procedure.

Insight 3: Article 26(6) moves the ban forward to the import stage. The prohibition on importing products whose expiry period has elapsed means that expiry verification must be completed before shipment, not remedied after arrival at port. Together with Article 21(1)(3), where the registration period expires before import, it forms two timing gates at the import stage.

Insight 4: Article 47(2) and Article 47(4) prescribe damage compensation for storage and transport violations and for destruction violations respectively. The subjects of liability under paragraph 2 are the entities carrying out wholesale and retail; the subject of liability under paragraph 4 is the violator of the destruction rules, and the scope of compensation includes environmental damage. This design writes environmental responsibility directly into the product liability provisions.

Insight 5: the technical procedures for destruction are dispersed across government resolutions and sanitary rules. Article 27(3) is only an enabling provision; the specific procedure is determined by the Ministry of Health, while the classification of medical waste is separately governed by Government Resolution No. 279 of June 2, 2011 and SanPiN 2.1.7.033-21. When carrying out destruction, companies must satisfy all three layers at once.

4. Practical recommendations

1. Do not establish any form of expiry extension process. Under Article 27(2), extension of the expiry period is prohibited and no extension channel exists for medical products; the internal quality system should expressly prohibit deferred release.
2. Move expiry verification forward to the shipping stage. Under Article 26(6), complete expiry verification before goods are dispatched and rule out remedial action after arrival at port.
3. Presuppose a destruction channel for products whose expiry period has elapsed. Under Article 27(3) and Article 21(1)(11), arrange local destruction resources and procedures in advance.
4. Allocate storage and transport responsibilities in distribution agreements. Under Article 47(2), define the storage and transport rules and the attribution of liability at the wholesale and retail stages.
5. Satisfy all three layers of destruction requirements simultaneously. Under Article 27(3), Government Resolution No. 279 of June 2, 2011 and SanPiN 2.1.7.033-21, the destruction plan must cover the statutory layer, the government resolution layer and the sanitary rules layer.

5. Verification checklist

• □ Confirmed that Article 27(2) prohibits extension of the expiry period and that no extension channel exists for medical products
• □ Confirmed that the expiry period and the period of use of medicinal substances are two distinct concepts
• □ Set an expiry verification node at the shipping stage (Article 26(6))
• □ Presupposed a local destruction channel for products whose expiry period has elapsed (Article 27(3))
• □ Allocated storage and transport responsibilities in distribution agreements (Article 47(2))
• □ Confirmed that the destruction plan covers the three layers of law, government resolution and sanitary rules
• □ Confirmed that the scope of compensation for destruction violations includes environmental damage (Article 47(4))

Regulatory information verified as of October 29, 2026.

In the Central Asia market, the core capabilities of GRZAN concentrate on three points. First, distinguishing the different legal positions of individual markets within the Eurasian Economic Union — Kazakhstan and Kyrgyzstan are full member states, where a national pathway and a Union pathway both exist; Uzbekistan is an observer state with only a national pathway; Tajikistan and Turkmenistan lie outside the Union framework and must proceed entirely under national procedures. Second, local authorized representative services, which may act as the statutory representative of manufacturers in these countries and assume registration submissions, regulatory communication and post-market reporting obligations. Third, quality system and testing support, assisting in establishing a quality management system that meets ISO 13485 requirements and connecting with locally accredited laboratory resources.

Business inquiries: info@grzanglobal.com